Page 2 - Diabetes Treatment

Glenmark launches fixed-dose combination medication for diabetic patients

Glenmark Pharmaceuticals on Monday said it has launched a novel fixed-dose combination (FDC) of Teneligliptin, with Pioglitazone in India for adults with uncontrolled Type 2 diabetes. Glenmark has launched this FDC under the brand name Zita Plus Pio, which contains Teneligliptin (20 mg) and Pioglitazone (15 mg), to be taken once a day, the company said in a statement. Diabetes is a key area of focus for Glenmark; a pioneer in providing access to the latest treatment options to diabetic patients in India. We are delighted to introduce this novel Zita Plus Pio, which is the first of its kind in India; offering a world-class and affordable treatment option to adult diabetic patients, Glenmark Pharmaceuticals Group Vice President & Head, India Formulations Alok Malik said. Glenmark claimed it is the "first company in India to market the innovative FDC of Teneligliptin + Pioglitazone, which is approved by the DCGI (Drug Controller General of India)" "This fixed-dose combination will be

Glenmark launches unique fixed dose combination drug for diabetes

Glenmark said it has become the first company in the world to launch the fixed dose combination drug in India

Ahead of World Diabetes Day, experts call for action to address epidemic

Ahead of World Diabetes Day, a new report has called for action to close the gap in diabetes prevention and care

Diabetes may cause infertility in men; here are some precautionary measures

Unhealthy food habits lead to weight gain and obesity, insulin resistance which in turn causes both diabetes and predisposes to infertility

Blood pressure drug may help prevent up to 60% of type 1 diabetes: Study

The drug, methyldopa, has been used for over 50 years to treat high blood pressure in pregnant women and children

Broccoli may help manage diabetes: Study

A chemical in broccoli tamped down glucose production by liver cells in rats

Once-a-month diabetes treatment may replace daily insulin jabs

In Primates treatment has shown to last for weeks, rather than days, says researchers